SunTrust Robinson Humphrey Initiates Coverage On Globus Medical with Buy Rating, Announces $67 Price Target

SunTrust Robinson Humphrey initiates coverage on Globus Medical (NYSE:GMED) with a Buy rating and a $67 price target.

Benzinga · 01/08/2020 14:52

SunTrust Robinson Humphrey initiates coverage on Globus Medical (NYSE:GMED) with a Buy rating and a $67 price target.